| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d3f1bfec8ac94cca9554e3c17db5c6d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
| filingDate |
2016-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b14705d98ad58d06321c8837904e32a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d68d9cca34a38edcb4d1d0d093936827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be2ff6eaf3dcddc073d287fa8a20ab62 |
| publicationDate |
2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MA-44205-B1 |
| titleOfInvention |
Orodispersible tablet comprising estetrol |
| abstract |
Disclosed is an orodispersible solid pharmaceutical dosage unit having a weight of between 30 and 1000 mg, said dosage unit containing at least 100 µg of an estetrol component selected from estetrol, estetrol esters and combinations thereof. -this; the solid dosage unit obtainable by a method which comprises the steps of: providing a charging liquid comprising an organic solvent; the estetrol component and optionally one or more other pharmaceutically acceptable ingredients; mixing 1 part by weight of the feed liquid with 0.5 to 20 parts by weight of carrier particles to produce wet particles; removing the organic solvent from the wet particles to produce charged particles; optionally mixing the charged particles with one or more tablet manufacturing excipients; and forming the charged particles or mixture of charged particles and the one or more tabletting excipients into a solid dosage unit. The solid dosage unit of the present invention is easy to manufacture and well suited for sublingual, buccal or sublabial administration. |
| priorityDate |
2015-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |